| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/17/2022 | Celldex Therapeutics, Inc. | CLDX | Exercise | Incentive Stock Option | 19k | $10.38 | $197.2k | | 08/17/2022 |
| 08/17/2022 | Celldex Therapeutics, Inc. | CLDX | Exercise | Incentive Stock Option | 45k | $2.71 | $122k | | 08/17/2022 |
| 08/17/2022 | Celldex Therapeutics, Inc. | CLDX | Sale | Common Stock | 19k | $37.30 | $708.7k | | 08/17/2022 |
| 06/16/2022 | Celldex Therapeutics, Inc. | CLDX | Grant | | 76k | $22.48 | $1.7M | | 06/16/2022 |
| 11/12/2021 | Celldex Therapeutics, Inc. | CLDX | Exercise | Incentive Stock Option (Right to Buy) | 4.6k | $10.38 | $47.7k | | 11/12/2021 |
| 11/12/2021 | Celldex Therapeutics, Inc. | CLDX | Sale | Common Stock | 4.6k | $42.94 | $197.5k | | 11/12/2021 |
| 06/17/2021 | Celldex Therapeutics, Inc. | CLDX | Grant | | 72k | $28.00 | $2M | | 06/17/2021 |
| 06/18/2020 | Celldex Therapeutics, Inc. | CLDX | Grant | | 72k | $10.38 | $747.4k | | 06/18/2020 |
| 06/11/2020 | Celldex Therapeutics, Inc. | CLDX | Purchase | Common stock, par value $0.001 per share | 2.1k | $4.73 | $10k | | 06/11/2020 |
| 07/08/2019 | Celldex Therapeutics, Inc. | CLDX | Grant | | 60k | $2.71 | $162.6k | | 07/08/2019 |
| 07/16/2018 | Oncternal Therapeutics, Inc. | GTXI | Sale | Common Stock | 2k | $14.70 | $30.1k | | 07/13/2018 |
| 07/16/2018 | Oncternal Therapeutics, Inc. | GTXI | Sale | Common Stock | 2k | $14.70 | $30.1k | | 07/13/2018 |
| 07/13/2018 | Oncternal Therapeutics, Inc. | GTXI | Payment of Exercise | Common Stock | 2k | $14.92 | $30k | | 07/13/2018 |
| 07/13/2018 | Oncternal Therapeutics, Inc. | GTXI | Payment of Exercise | Common Stock | 2k | $14.92 | $30k | | 07/13/2018 |
| 01/01/2018 | Oncternal Therapeutics, Inc. | GTXI | Grant | Employee Stock Option (Right to Buy) | 25k | $12.71 | $317.8k | | 01/01/2018 |
| 02/28/2017 | Oncternal Therapeutics, Inc. | GTXI | Grant | Employee Stock Option (Right to Buy) | 50k | $4.71 | $235.5k | | 02/28/2017 |